Log in
OTCMKTS:NWPHF

Newron Pharmaceuticals Stock Forecast, Price & News

$2.55
0.00 (0.00 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$2.55
Now: $2.55▼
$2.55
50-Day Range
$2.00
MA: $2.41▼
$2.55
52-Week Range
$1.80
Now: $2.55▼
$8.90
VolumeN/A
Average Volume295 shs
Market Capitalization$45.52 million
P/E RatioN/A
Dividend YieldN/A
Beta0.36
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease. Its pipeline of products include Sarizotan for patients with Rett syndrome; Evenamide, a first add-on therapy for the treatment of patients with positive symptoms of schizophrenia; and Ralfinamide for patients with specific rare pain indications. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.
Read More
Newron Pharmaceuticals logo

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.42 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NWPHF
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.newron.com
Phone39026103461
Employees26

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$7.88 million
Price / Sales5.78
Cash FlowN/A
Price / Cash FlowN/A
Book Value$2.31 per share
Price / Book1.10

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares17,850,000
Market Cap$45.52 million
Next Earnings DateN/A
OptionableNot Optionable
$2.55
0.00 (0.00 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NWPHF News and Ratings via Email

Sign-up to receive the latest news and ratings for NWPHF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Newron Pharmaceuticals (OTCMKTS:NWPHF) Frequently Asked Questions

How has Newron Pharmaceuticals' stock been impacted by COVID-19?

Newron Pharmaceuticals' stock was trading at $7.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NWPHF stock has decreased by 66.0% and is now trading at $2.55.
View which stocks have been most impacted by COVID-19.

Are investors shorting Newron Pharmaceuticals?

Newron Pharmaceuticals saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 1,600 shares, an increase of 1,500.0% from the September 15th total of 100 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.
View Newron Pharmaceuticals' Short Interest.

Who are some of Newron Pharmaceuticals' key competitors?

Some companies that are related to Newron Pharmaceuticals include NuCana (NCNA), CorMedix (CRMD), Matinas BioPharma (MTNB), Enlivex Therapeutics (ENLV), Matinas BioPharma (MTNB), Aquestive Therapeutics (AQST), Heat Biologics (HTBX), Chimerix (CMRX), Taiwan Liposome (TLC), Cerecor (CERC), OptiNose (OPTN), Veru (VERU), Sol-Gel Technologies (SLGL), LifeVantage (LFVN) and Mustang Bio (MBIO).
View all competitors.

Who are Newron Pharmaceuticals' key executives?

Newron Pharmaceuticals' management team includes the following people:
  • Mr. Stefan Weber, CEO & Exec. Director (Age 55)
  • Mr. Roberto Galli, VP of Fin.
  • Mr. Marco Caremi, Exec. VP of Bus. Devel. (Age 63)
  • Dr. Ravi Anand, Chief Medical Officer (Age 63)

What is Newron Pharmaceuticals' stock symbol?

Newron Pharmaceuticals trades on the OTCMKTS under the ticker symbol "NWPHF."

How do I buy shares of Newron Pharmaceuticals?

Shares of NWPHF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Newron Pharmaceuticals' stock price today?

One share of NWPHF stock can currently be purchased for approximately $2.55.

How big of a company is Newron Pharmaceuticals?

Newron Pharmaceuticals has a market capitalization of $45.52 million and generates $7.88 million in revenue each year. The company earns $-22,630,000.00 in net income (profit) each year or ($1.27) on an earnings per share basis. Newron Pharmaceuticals employs 26 workers across the globe.

What is Newron Pharmaceuticals' official website?

The official website for Newron Pharmaceuticals is www.newron.com.

How can I contact Newron Pharmaceuticals?

Newron Pharmaceuticals' mailing address is via Antonio Meucci 3 Milan, Bresso L6, 20091. The company can be reached via phone at 39026103461 or via email at [email protected]

This page was last updated on 10/25/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.